Sponsored message
Logged in as
Audience-funded nonprofit news
radio tower icon laist logo
Next Up:
0:00
0:00
 — 
See All Episodes
Subscribe

Hey, LA listener!

Download our app for the optimal streaming experience

Apple Store logo Google play logo
  • Listen Now Playing Listen
  • Listen Now Playing Listen
Take Two

Big pharma's push for the female 'viagra' pill, Osphena

By Take Two Staff
Published May 1, 2013
AURORA, CO - MARCH 27: Pharmacy director Hank Wedemeyer looks up records while filling a prescription at a community health center on March 27, 2012 in Aurora, Colorado. The center, called the Metro Community Provider Network, has received some 6,000 more Medicaid eligable patients since the healthcare reform law was passed in 2010. Expansion of such clinics nationwide is considered key to serving the millions more patients set to be be covered by Medicaid if the healthcare reform passes the current challenge in the Supreme Court. Preventative health services and treatments at community health centers are also designed to reduce emergency room expenditures, which are up to 10 times more costly. (Photo by John Moore/Getty Images)
Pharmacy director Hank Wedemeyer looks up records while filling a prescription at a community health center on March 27, 2012 in Aurora, Colorado.
(
John Moore/Getty Images
)

Take Two translates the day’s headlines for Southern California, making sense of the news and cultural events that affect our lives. Produced by Southern California Public Radio and broadcast from October 2012 – June 2021. Hosted by A Martinez.

Get LA News Updates Daily

We brief you on what you need to know about L.A. today.
Listen 5:45
Big pharma's push for the female 'viagra' pill, Osphena

The Food and Drug Administration recently approved a drug called Osphena, a drug that some are calling the female equivalent of viagra. It's headed to market next month.

Its makers claim it will help women who experience painful sex during menopause, and are hoping it will be the next blockbuster drug. But do women really need it? Jennifer Block has been writing about this medication for Newsweek, she joins the show with more.